SI-BONE, Inc. (SIBN): Entry into a Material Definitive Agreement
SI-BONE, Inc. (SIBN) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry into a Material Definitive Agreement. On September 11, 2026, SI-BONE, Inc. (the “Company”) and BIXBY SPE FINANCE 11, LLC (“Landlord”) entered into the Fourth Amendment to Lease (the “Fourth Lease Amendment”) to the Office Lease Agreement dated as of February 2, 2
How this was made
The 30-second read
Why it matters
The recall introduces a modest cost charge and may raise short‑term quality concerns, while the lease extension has negligible financial effect.
Market read
Primary disclosure of a recall and lease amendment; modest impact on SI-BONE's stock price.
What to watch
Potential recovery of costs from the tube manufacturer and no impact on revenue.
Background
SI-BONE filed an 8‑K reporting a lease amendment and a product recall, the first public disclosure of these events.
Ticker impact
SI-BONE disclosed a voluntary recall of 98 iFuse TORQ implants and a lease amendment, estimating up to $150,000 charge to cost of goods sold.
slight dip or flat as investors price in $150k charge
The disclosed charge is small relative to revenue, but recall risk can affect perception of product quality.
Market effects
Medical device sector may see heightened scrutiny on packaging quality.
Limited to U.S. healthcare providers using the product.
Minimal; recall size is small and company is niche.
Counterpoint
The recall cost is negligible; the stock could rebound if the issue is resolved quickly.
Key entities
- CompanySI-BONE, Inc.
Medical device manufacturer of spinal implants.
- LandlordBIXBY SPE FINANCE 11, LLC
Owner of SI-BONE's corporate headquarters lease.
